Ty Roush is a New York City-based breaking news reporter who frequently covers Russia’s invasion of Ukraine, the automotive industry and sports money. He joined Forbes in 2022 and has covered Exxon acquiring Pioneer for nearly $60 billion, a mysterious respiratory illness affecting dogs across the U.S.
Eli Lilly ’s weight loss and diabetes injection tirzepatide—the active ingredient in Zepbound and Mounjaro —could improve symptoms of heart failure in patients with obesity, the company said Thursday, the latest findings suggesting the increasingly popular medications for weight loss and diabetes could have cardiovascular benefits.
Tirzepatide also resulted in an average weight loss of 15.7% in patients with and without type 2 diabetes, compared with 2.2% in a group that used a placebo.We’re launching text message alerts so you'll always know the biggest stories shaping the day’s headlines. Text “Alerts” to 335-0739 or sign upto the Centers for Disease Control and Prevention. Heart failure was responsible for nearly 14% of all deaths in the U.S. in 2022.
Zepbound Mounjaro Ozempic Wegovy
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage studyThe data adds to mounting evidence that Zepbound and other popular GLP-1 drugs have health benefits beyond promoting weight loss and regulating blood sugar.
Read more »
Eating disorders rise amid popular weight loss medications Wegovy and Zepbound—Is there a link?Liz Szabo is an independent health and science journalist. Her work has won multiple national awards. One of her investigations led to a new state law in Virginia.
Read more »
Zepbound outperforms Ozempic and Wegovy in head-to-head weight loss studyThe World Health Organization issued an alert on falsified versions of Ozempic, the popular drug used to treat type 2 diabetes and obesity. The WHO warned health care professionals and the public to be aware of the counterfeits, which it said are increasing as demand for the drugs grows. NBC News' Anne Thompson reports.
Read more »
Pfizer targets obesity with new once-daily Danuglipron drugCurrent FDA approved weight loss meds Wegovy and Zepbound are weekly injections.
Read more »
Zepbound Sheds More Weight Than Wegovy, Study FindsRobert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.
Read more »
Micah Parsons reveals weight loss; down to college playing weightDallas Cowboys superstar Micah Parsons is taking on a versatile role in new defensive coordinator Mike Zimmer's system, and he'll be lighter on his feet.
Read more »